The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prediction of fluoropyrimidine toxicities by screening DPYD genetic variants.
M. Del Re
No relevant relationships to disclose
F. Loupakis
No relevant relationships to disclose
A. Michelucci
No relevant relationships to disclose
A. Di Paolo
No relevant relationships to disclose
A. Falcone
No relevant relationships to disclose
P. Simi
No relevant relationships to disclose
G. Bocci
No relevant relationships to disclose
M. Cantore
No relevant relationships to disclose
R. Bordonaro
No relevant relationships to disclose
A. Di Leo
No relevant relationships to disclose
C. Barbara
No relevant relationships to disclose
F. Cappuzzo
No relevant relationships to disclose
F. G. De Braud
No relevant relationships to disclose
R. Danesi
No relevant relationships to disclose